Yoshioka S, Aso Y, Izutsu K, Kojima S
National Institute of Health Sciences, Tokyo, Japan.
Pharm Res. 1994 Dec;11(12):1721-5. doi: 10.1023/a:1018955031042.
Denaturation and aggregation kinetics of Aspergillus oryzae beta-galactosidase in solution were studied in order to determine whether the stability of protein drugs can be predicted. Denaturation of beta-galactosidase, monitored by measuring enzyme activity, conformed to first-order kinetics, whereas aggregation of the denatured form, monitored by high performance size exclusion chromatography, showed a reaction order higher than 1. Denaturation of beta-galactosidase was irreversible and exhibited a biphasic kinetic pattern which could be explained by assuming that two isoenzymes denatured irreversibly at different rates. Linear Arrhenius plots were obtained for the estimated rate constants, and delta H not equal to and delta S++ to were estimated according to the Eyring equation. The estimated delta H++ was much larger than delta H++ observed in usual chemical reactions. The present study suggests that the denaturation of protein drugs can be analyzed by the Eyring equation in the same manner as chemical degradation, contradicting the general consensus that accelerated testing can not be used to predict the stability of protein formulations.
为了确定蛋白质药物的稳定性是否可以预测,研究了米曲霉β-半乳糖苷酶在溶液中的变性和聚集动力学。通过测量酶活性监测β-半乳糖苷酶的变性,符合一级动力学,而通过高效尺寸排阻色谱监测变性形式的聚集,显示反应级数高于1。β-半乳糖苷酶的变性是不可逆的,呈现双相动力学模式,这可以通过假设两种同工酶以不同速率不可逆变性来解释。获得了估计速率常数的线性阿伦尼乌斯图,并根据艾林方程估计了ΔH≠和ΔS++。估计的ΔH++比通常化学反应中观察到的ΔH++大得多。本研究表明,蛋白质药物的变性可以用艾林方程以与化学降解相同的方式进行分析,这与加速试验不能用于预测蛋白质制剂稳定性的普遍共识相矛盾。